Impact of low molecular weight heparin administration on the clinical course of the COVID-19 disease

BACKGROUND: Lymphopenia is the most important criterion of mortality and discharging feature for patients infected with coronavirus disease 2019 (COVID-19). This study aimed to investigate the clinical impact of a low molecular weight heparin (LMWH) treatment on the clinical course of COVID-19. MATE...

Descripción completa

Detalles Bibliográficos
Autores principales: YORMAZ, Burcu, ERGÜN, Dilek, TÜLEK, Baykal, ERGÜN, Recai, ARSLAN, Uğur, KANAT, Fikret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991848/
https://www.ncbi.nlm.nih.gov/pubmed/32892540
http://dx.doi.org/10.3906/sag-2006-184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991848/
https://www.ncbi.nlm.nih.gov/pubmed/32892540
http://dx.doi.org/10.3906/sag-2006-184

Ejemplares similares